Literature DB >> 4602675

Trial of placebo in long-term chlorpropamide-treated diabetics.

A Lev-Ran.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4602675     DOI: 10.1007/bf00423034

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL.

Authors:  J SHELDON; J ANDERSON; L STONER
Journal:  Diabetes       Date:  1965-06       Impact factor: 9.461

2.  Remission in diabetes.

Authors:  A BLOOM
Journal:  Br Med J       Date:  1959-10-17

3.  Tolbutamide in diabetes; some clinical and biochemical studies.

Authors:  M F CROWLEY; F W WOLFF; A BLOOM
Journal:  Br Med J       Date:  1957-08-10

4.  [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].

Authors:  C Aiello; D Turner; N J Aparicio; E A De Turner; A Vazquez
Journal:  Acta Diabetol Lat       Date:  1973 Jan-Feb

5.  The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

Authors:  P C Chu; M J Conway; H A Krouse; C J Goodner
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

6.  A paradoxical effect of chlorpropamide on the plasma glucose and immunoreactive insulin response to intravenous glucose in normal dogs.

Authors:  G M Reaven; T S Lindley; J R Weisinger; R S Swenson
Journal:  Diabetes       Date:  1973-05       Impact factor: 9.461

7.  Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect.

Authors:  A Hecht; H Gershberg; M Hulse
Journal:  Metabolism       Date:  1973-05       Impact factor: 8.694

8.  Glucose intolerance retested. The importance of variability and a vindication of restriction of dietary carbohydrate.

Authors:  W P Jackson; J Kalk; A Whisson; A Hardcastle; M G Toyer
Journal:  S Afr Med J       Date:  1972-12-30

9.  Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.

Authors:  G Reaven; J Dray
Journal:  Diabetes       Date:  1967-07       Impact factor: 9.461

10.  Assessment of the need for continued oral therapy in diabetics.

Authors:  A M Tomkins; A Bloom
Journal:  Br Med J       Date:  1972-03-11
View more
  5 in total

1.  The oral hypoglycemics: boon or bane?

Authors:  A Kenshole
Journal:  Can Fam Physician       Date:  1975-11       Impact factor: 3.275

Review 2.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 3.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

4.  Wide variation in serum chlorpropamide concentration in outpatients.

Authors:  U Bergman; I Christenson; B Jansson
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

Review 5.  Diabetes in African Americans: unique pathophysiologic features.

Authors:  Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 5.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.